Mohammed Alissa

1.6k citations
128 papers · 925 indexed · h-index 16

Mohammed Alissa

106 papers receiving 903 citations

Peers

Mohammed Alissa
Comparison fields: 5 of 133
  • Pharmaceutical Science 94
  • Molecular Medicine 71
  • Virology 55
  • Applied Microbiology and Biotechnology 23
  • Biomaterials 113
Replace Anna Maria Schito with:
Anna Maria Schito Italy
Admire Dube South Africa
Bwalya A. Witika South Africa
Emrah Şefik Abamor Türkiye
Mohsen Amin Iran
Kishore Bhat India
Abida Raza Pakistan
Setareh Haghighat Iran
Fulwah Yahya Alqahtani Saudi Arabia
Jyoti Jyoti India
Mohammed Alissa relative to Anna Maria Schito Italy Anna Maria Schito's profile →
Citations per field
00.5×1.5×2.4×
Anna Maria Schito · 1×
Citations per year

Countries citing papers authored by Mohammed Alissa

Since Specialization
Citations

This map shows the geographic impact of Mohammed Alissa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Alissa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Alissa more than expected).

Fields of papers citing papers by Mohammed Alissa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammed Alissa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Alissa. The network helps show where Mohammed Alissa may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mohammed Alissa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mohammed Alissa Line = papers co-authored together Mohammed Alissa links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20255
2 20252
3 20250
4 20251
5 20241
6 20243
7 20245
8 20248
9 20243
10 20241
11 20241
12 20245
13 20242
14 20242
15 20247
16 20243
17 202323
18 202316
19 20233
20 202328

About Mohammed Alissa

Mohammed Alissa is a scholar working on Pharmaceutical Science, Virology and Molecular Medicine, having authored 128 papers that have together received 925 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (11 papers), Poxvirus research and outbreaks (8 papers), Advancements in Transdermal Drug Delivery (8 papers), Wound Healing and Treatments (7 papers), Nanoparticles: synthesis and applications (7 papers), Mosquito-borne diseases and control (7 papers), Drug Solubulity and Delivery Systems (6 papers) and Enzyme Production and Characterization (6 papers). The work is most often cited by research in Pharmaceutical Science (94 citations), Molecular Medicine (71 citations) and Virology (55 citations). Mohammed Alissa has collaborated with scholars based in Saudi Arabia, Pakistan and China. Frequent co-authors include Khaled M. Hosny, Ali A. Rabaan, Waleed Y. Rizg, Mohammed Garout, Ahmad A. Alshehri, Umber Zaman, Khalil ur Rehman, Mohammed Majrashi, Mohammed Aljeldah and Hala M. Alkhalidi. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Agricultural and Food Chemistry and Coordination Chemistry Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026